Botulinum toxin injection for abductor spasmodic dysphonia under cervical ultrasonography guidance

被引:1
|
作者
Kunieda, Chikako [1 ,8 ]
Nin, Fumiaki [1 ,2 ]
Ohashi, Toshimitsu [1 ,3 ]
Hosokawa, Kiyohito [4 ]
Watanabe, Yusuke [5 ]
Ogawa, Takenori [3 ]
Mori, Tomohiro [6 ]
Kanazawa, Takeharu [7 ]
机构
[1] Hashima City Hosp, Dept Otolaryngol, Gifu, Japan
[2] Gifu Univ, Grad Sch Med, Dept Physiol, Div Biol Principles, Gifu, Japan
[3] Gifu Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Gifu, Japan
[4] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan
[5] Int Univ Hlth & Welf, Tokyo Voice Ctr, Tokyo, Japan
[6] Hashima City Hosp, Dept Radiol, Gifu, Japan
[7] Jichi Med Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Shimotsuke, Tochigi, Japan
[8] Hashima City Hosp Gifu, Dept Otolaryngol, 3-246 Shinsei Town, Hashima city, Gifu 5016206, Japan
关键词
Ultrasound; Visualization; Botulinum toxin; Abductor spasmodic dysphonia;
D O I
10.1016/j.anl.2023.09.008
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Ultrasound (US) imaging effectively provides real -time anatomical information for clinical examinations. In otolaryngology, US imaging can visualize laryngeal muscles as well as cervical muscles. Here we present the case where US imaging was used while injecting botulinum toxin (BT) for the treatment of abductor spasmodic dysphonia, which provided definite results. We could visualize not only the injection pathway but also the infiltration of the BT solution into the posterior cricoarytenoid muscles. Therefore, our laryngeal US imaging is useful for both improving the success rate and avoiding injection complications of BT.
引用
收藏
页码:361 / 364
页数:4
相关论文
共 50 条
  • [21] PHARMACOLOGICAL AGENTS THAT IMPROVE BOTULINUM TOXIN EFFICACY IN THE TREATMENT OF SPASMODIC DYSPHONIA
    ZEALEAR, DL
    STONE, RE
    DISIMONE, AG
    STONE, RE
    NETTERVILLE, JL
    JOURNAL OF VOICE, 1992, 6 (04) : 387 - 393
  • [22] Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia
    Anari, Shahram
    Carding, Paul N.
    Hawthorne, Maurice R.
    Deakin, Jayne
    Drinnan, Michael J.
    LARYNGOSCOPE, 2007, 117 (10) : 1888 - 1892
  • [23] Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia
    Langeveld, TPM
    Drost, HA
    DE Jong, RJB
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1998, 107 (04) : 280 - 284
  • [24] Botulinum toxin type B for treatment of spasmodic dysphonia: A case report
    Sataloff, RT
    Heman-Ackah, YD
    Simpson, LL
    Park, JB
    Zwislewski, A
    Sokolow, C
    Mandel, S
    JOURNAL OF VOICE, 2002, 16 (03) : 422 - 424
  • [25] Botulinum toxin treatment for spasmodic dysphonia:: Percutaneous versus transoral approach
    Ruiz, PJG
    Español, CC
    Bernardos, VS
    Astarloa, R
    Sanabria, J
    de Yébenes, JG
    CLINICAL NEUROPHARMACOLOGY, 1998, 21 (03) : 196 - 198
  • [26] TREATMENT OF SPASMODIC DYSPHONIA (LARYNGEAL DYSTONIA) WITH LOCAL INJECTIONS OF BOTULINUM TOXIN
    BLITZER, A
    BRIN, MF
    JOURNAL OF VOICE, 1992, 6 (04) : 365 - 369
  • [27] Effects of botulinum toxin on vocal tract steadiness in patients with spasmodic dysphonia
    Zwirner, P
    Murry, T
    Woodson, GE
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1997, 254 (08) : 391 - 395
  • [28] Factors Influencing Botulinum Toxin Dose Instability in Spasmodic Dysphonia Patients
    Rosow, David E.
    Pechman, Amanda
    Saint-Victor, Sandra
    Lo, Kaming
    Lundy, Donna S.
    Casiano, Roy R.
    JOURNAL OF VOICE, 2015, 29 (03) : 352 - 355
  • [29] Long-term effects of botulinum toxin injections in spasmodic dysphonia
    Davidson, BJ
    Ludlow, CL
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1996, 105 (01) : 33 - 42
  • [30] Considerations for Initial Dosing of Botulinum Toxin in Treatment of Adductor Spasmodic Dysphonia
    Rosow, David E. E.
    Parikh, Punam
    Vivero, Richard J. J.
    Casiano, Roy R. R.
    Lundy, Donna S. S.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2013, 148 (06) : 1003 - 1006